Advanced Solid Tumors or Lymphomas
3 clinical trials · Condition
◉ Watch Advanced Solid Tumors or Lymphomas
| Record | Firm | Date |
|---|---|---|
| Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement (NCT06073938) | Hunan Province Tumor Hospital | 2022-09-20 |
| A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas (NCT05374226) | Suzhou Kebo Ruijun Biotechnology Co., Ltd | 2022-03-31 |
| A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas (NCT02812875) | Curis, Inc. | 2016-05-01 |
Track Advanced Solid Tumors or Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.